913828-75-8

Basic information

• Product Name: 4-ethynylthiophene-2-carbaldehyde
• Synonyms: 4-ethynylthiophene-2-carbaldehyde
• CAS NO: 913828-75-8
• Molecular Formula: C7H4OS
• Molecular Weight: 136.17106
• Mol File: 913828-75-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-ethynylthiophene-2-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ethynylthiophene-2-carbaldehyde(913828-75-8)
• EPA Substance Registry System: 4-ethynylthiophene-2-carbaldehyde(913828-75-8)

Safety Data

• Hazardous Substances Data: 913828-75-8(Hazardous Substances Data)

Upstream product

• 18791-75-8 4-Bromothiophen-2-aldehyde 
• 859809-18-0 4-((trimethylsilyl)ethynyl)thiophene-2-carbaldehyde 

Downstream Products

• 1028947-13-8 C₂₄H₃₃NO₂SSi 

Relevant articles and documents

NOVEL COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE 6 AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to a new compound having an inhibitory activity of histone deacetylase 6 (HDAC6), stereoisomers thereof, pharmaceutically acceptable salts thereof, a use thereof in the preparation of a drug, a pharmaceutical composition comprising them, a prophylactic or therapeutic method corresponding, and a method of preparing a new derivative 1,3,4-oxadiazole triazol, a novel compound having selective HDAC6 inhibitory activity being represented by the following chemical formula I.

Opioid receptor agonists and application thereof

The invention discloses compounds and salts thereof that can be used as opioid receptor ligands, a preparation method of the compounds, compositions containing the compounds, and a use of the compounds as [mu] opioid receptor agonists; the compounds are used for treatment of [mu] opioid receptor-mediated related diseases, such as pains and pain-related disorders.

HETEROCYCLIC COMPOUND

[Object] To provide a novel compound having an excellent immunosuppressive activity with low toxicity or a pharmacological salt thereof. [Means to achieve the object] A compound having general formula (I) shown below or a pharmacologically acceptable salt thereof, or a pharmacologically acceptable prodrug thereof [wherein A represents a carboxyl group, or the like, B represents a hydrogen atom, or the like, V represents a single bond, a methylene group, or the like, n represents an integer of from 0 to 2, W represents a 5- to 7-membered heterocyclic group, or the like, Z represents a group selected from Substituent group A, or the like, and Substituent group A represents the group consisting of a halogen atom, a C1-C6 alkyl group, a C3-C7 cycloalkyl group.